Scientific publications on subjects and technologies related to Diamyd Medicals research and activities.

Immunotherapy with Diamyd® (GAD65)

  Antigen-based Immunotherapy Improves Glycemic Metrics and β-Cell Function
J Clin Endocrinol Metab. 2022 Jul 26;dgac437.
  More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes
N Engl J Med. 2017 Jul 27;377(4):403
  Intralymphatic Injection of Autoantigen in Type 1 Diabetes
N Engl J Med. 2017 Feb 16;376(7):697-699

Order GAD for preclinical research

GAD PRODUCTS